Fevipiprant

Description: Fevipiprant / NVP-QAW039 / QAW039, is an oral active and potent CRTh2 receptor antagonist and potentially useful for asthma treatment.

• Catalog: OFC872365145
• CAS: 872365-14-5
• Category: Fluorinated APIs
• Synonyms: NVP-QAW039
• Purity: >98%

• IUPAC Name: 2-[2-methyl-1-[[4-methylsulfonyl-2-(trifluoromethyl)phenyl]methyl]pyrrolo[2,3-b]pyridin-3-yl]acetic acid
• InChI: InChI=1S/C19H17F3N2O4S/c1-11-15(9-17(25)26)14-4-3-7-23-18(14)24(11)10-12-5-6-13(29(2,27)28)8-16(12)19(20,21)22/h3-8H,9-10H2,1-2H3,(H,25,26)
• InChI Key: GFPPXZDRVCSVNR-UHFFFAOYSA-N
• Isomeric SMILES: CC1=C(C2=C(N1CC3=C(C=C(C=C3)S(=O)(=O)C)C(F)(F)F)N=CC=C2)CC(=O)O

• Molecular Formula: C19H17F3N2O4S
• Molecular Weight: 426.41
• Appearance: White to off-white solid powder

• XLogP3-AA: 2.8
• Hydrogen Bond Donor Count: 1
• Hydrogen Bond Acceptor Count: 8
• Rotatable Bond Count: 5
• Exact Mass: 426.08611269 g/mol
• Monoisotopic Mass: 426.08611269 g/mol
• Topological Polar Surface Area: 97.6Ų
• Heavy Atom Count: 29
• Formal Charge: 0
• Complexity: 709